News

Nutriband Inc. to Manufacture Fleur Marché-branded Wellness Patches Under Exclusive Agreement

Read More »

October 27, 2022

News

Nutriband Subsidiary, 4P Therapeutics LLC, Conducts Phase 1b Clinical Study for Sorrento Therapeutics, Inc. on Lymphatic Etanercept Delivery in Rheumatoid Arthritis Patients With Results To Be Presented at the 2022 American College of Rheumatology Conference

Read More »

October 26, 2022

News

Nutriband Inc. Invited to Present at the 2023 Transdermal and Microneedle Conference in London on January 23 and 24

Read More »

October 17, 2022

News

Nutriband with Kindeva Drug Delivery demonstrate enhanced abuse-deterrent characteristics for Aversa™ Fentanyl

Read More »

October 4, 2022

News

Nutriband Inc. Announces Application for Dual Listing on Upstream

Read More »

October 3, 2022

News

Nutriband Inc. Reports Revenue Up 113% YoY in Q2

Read More »

September 8, 2022

News

Nutriband Inc. Provides Update on Seven-for-Six Forward Stock Split

Read More »

August 16, 2022

News

Nutriband Inc. Details of Seven-for-Six Forward Stock Split.

Read More »

August 10, 2022

News

Nutriband Receives Notice of Allowance from the Canadian Intellectual Property Office for its AVERSA™ Abuse Deterrent Transdermal Technology Patent

Read More »

August 1, 2022